SOURCE: MusclePharm

MusclePharm

September 19, 2014 08:00 ET

MusclePharm Launches CocoProtein™ Sports Drink at Mr. Olympia Expo

Coconut Water + Protein Combination Brings New Innovation to Beverage Market

DENVER, CO and LAS VEGAS, NV--(Marketwired - Sep 19, 2014) - Coinciding with the Mr. Olympia 2014 Expo in Las Vegas, MusclePharm Corporation (OTCQB: MSLP), a scientifically driven, performance-lifestyle sports nutrition company, announced the launch of CocoProtein™, the first all-natural ready-to-drink sports beverage that combines protein and coconut water into one convenient, great-tasting product.

Created for every type of fitness enthusiast lifestyle, whether running, lifting, hiking, or simply on the go, CocoProtein provides important vitamins, minerals and protein to build lean muscle, increase endurance, fuel recovery, and stay hydrated. Naturally gluten-free, lactose-free, and dairy-free, each bottle of CocoProtein contains 20 grams of protein and more potassium than a banana.

"CocoProtein is the perfect complement to any workout and healthy lifestyle, with an excellent flavor profile and a smooth and light texture," said Brad Pyatt, CEO of MusclePharm. "The launch also marks our entrance into the beverage industry, an exciting new growth area for our company, with an innovative and differentiated product that underscores our commitment to fuel sport."

CocoProtein will debut on October 1, 2014 in two delicious flavors: Chocolate and Piña Colada and will be available initially at GNC, Vitamin Shoppes, Bodybuilding.com, as well as select Costco Stores. CocoProtein will be distributed domestically by Europa Sports. The product is available for tasting at MusclePharm's CocoProtein booth at the Olympia Expo September 19-21.

About MusclePharm
MusclePharm® is a scientifically-driven, performance lifestyle company that currently develops, manufactures, markets and distributes branded nutritional supplements. The company offers a complete range of powders, capsules, tablets and gels. Its portfolio of recognized brands, including MusclePharm® Hybrid and Core Series, Arnold Schwarzenegger Series™ and FitMiss™, are marketed and sold in more than 110 countries and available in over 35,000 retail outlets globally. These clinically-proven and scientific nutritional supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit www.musclepharm.com.

Follow the company at http://www.facebook.com/MusclePharm and www.Twitter.com/MusclePharm

To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2013, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.

Contact Information